Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Ceptyr
company
About
Ceptyr is a developer of protein tyrosine phosphatase (PTP) -based therapeutics.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $11.50M
- Industries
- Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 1995
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Ceptyr, Inc was founded to focus on developing drugs against protein tyrosine phosphatases (PTPs), a largely unexplored niche in pharmaceutical development.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$31.50M
Ceptyr has raised a total of
$31.50M
in funding over 2 rounds. Their latest funding was raised on
Dec 23, 2002 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 23, 2002 | Series Unknown | $20M | 1 | — | — | Detail |
| Aug 18, 1999 | Series Unknown | $11.50M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Ceptyr is funded by 2 investors.
ARCH Venture Partners
and Falcon
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series Unknown |
Falcon
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
